1. Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C. Issue 12 (21st September 2010) Authors: Moucari, Rami; Forestier, Nicole; Larrey, Dominique; Guyader, Dominique; Couzigou, Patrice; Benhamou, Yves; Voitot, Hélène; Vidaud, Michel; Seiwert, Scott; Bradford, Bill; Zeuzem, Stefan; Marcellin, Patrick Journal: Gut Issue: Volume 59:Issue 12(2010) Page Start: 1694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗